BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23977537)

  • 1. Important recent insights into the genetics and biology of malignant pleural mesothelioma.
    McMillan R; Zauderer M; Bott M; Ladanyi M
    Ann Cardiothorac Surg; 2012 Nov; 1(4):462-5. PubMed ID: 23977537
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma.
    Moro J; Sobrero S; Cartia CF; Ceraolo S; Rapanà R; Vaisitti F; Ganio S; Mellone F; Rudella S; Scopis F; La Paglia D; Cacciatore CC; Ruffini E; Leo F
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the biology of malignant pleural mesothelioma.
    Zucali PA; Ceresoli GL; De Vincenzo F; Simonelli M; Lorenzi E; Gianoncelli L; Santoro A
    Cancer Treat Rev; 2011 Nov; 37(7):543-58. PubMed ID: 21288646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.
    Weiner SJ; Neragi-Miandoab S
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):15-27. PubMed ID: 18787841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of preclinical models for malignant pleural mesothelioma.
    Shamseddin M; Obacz J; Garnett MJ; Rintoul RC; Francies HE; Marciniak SJ
    Thorax; 2021 Nov; 76(11):1154-1162. PubMed ID: 33692175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma.
    Alchami FS; Attanoos RL; Bamber AR
    J Clin Pathol; 2017 Feb; 70(2):179-182. PubMed ID: 27798081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant pleural fluid from mesothelioma has potent biological activities.
    Cheah HM; Lansley SM; Varano Della Vergiliana JF; Tan AL; Thomas R; Leong SL; Creaney J; Lee YC
    Respirology; 2017 Jan; 22(1):192-199. PubMed ID: 27560254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleolin and nucleophosmin expression patterns in pulmonary adenocarcinoma invading the pleura and in pleural malignant mesothelioma.
    Masiuk M; Waloszczyk P; Lewandowska M; Dobak E; Urasinska E
    Thorac Cancer; 2020 Sep; 11(9):2529-2535. PubMed ID: 32671956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects].
    Mohr S; Keith G; Rihn B
    Bull Cancer; 2005 Nov; 92(11):959-76. PubMed ID: 16316830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma.
    Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Iwasaki A; Nabeshima K
    Mod Pathol; 2020 Feb; 33(2):235-244. PubMed ID: 31231129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.
    Sneddon S; Dick I; Lee YCG; Musk AWB; Patch AM; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
    Lung Cancer; 2018 May; 119():64-70. PubMed ID: 29656754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of malignant pleural mesothelioma.
    Rodríguez Panadero F
    Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural mesothelioma.
    Kindler HL
    Curr Treat Options Oncol; 2000 Oct; 1(4):313-26. PubMed ID: 12057157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
    Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
    Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
    Vivero M; Bueno R; Chirieac LR
    Mod Pathol; 2018 Jan; 31(1):122-131. PubMed ID: 28884745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for malignant pleural mesothelioma: why, when and what?
    Lang-Lazdunski L
    Lung Cancer; 2014 May; 84(2):103-9. PubMed ID: 24602395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining.
    Kwee WS; Veldhuizen RW; Golding RP; Mullink H; Stam J; Donner R; Boon ME
    Virchows Arch A Pathol Anat Histol; 1982; 397(3):287-99. PubMed ID: 6186071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma.
    Attanoos RL; Gibbs AR
    Histopathology; 2008 Sep; 53(3):340-4. PubMed ID: 18647189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant pleural mesothelioma with an unusual radiologic manifestation].
    Jover-Sáenz A; Vilà-Justribó M; Salud-Salvià A; Porcel-Pérez JM; Vicente de Vera P
    An Med Interna; 1999 Jul; 16(7):354-6. PubMed ID: 10481335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not everything is what it seems: malignant pleural mesothelioma mimicking lung cancer.
    Prisciandaro E; Girelli L; Rampinelli C; Ghioni M; Spaggiari L
    Adv Respir Med; 2019; 87(6):265-267. PubMed ID: 31970729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.